In terms of LINC00261, Liu et al. [47] demonstrated that LINC00261, as a tumor suppressor, can be inactivated by methylation of promoter region, while the demethylation could upregulate LINC00261 and inhibit the progress of pancreatic cancer. The gene discussed is LINC00261; the disease is pancreatic neoplasm.